Blue Ocean Capital Group is a life-science venture capital firm investing in biotechnology, medical devices and health technology across Greater China, the United States and Northern Europe. It backs research commercialization and helps portfolio companies develop products, operating teams and international partnerships. Its investment themes include RNA drugs, gene and cell therapies, AI drug discovery, medical imaging and digital health; its specialist seed strategy also targets brain-computer interfaces and neuroscience.
Founded
2015
Type
Venture capital
Funds1
深圳市蓝海智脑光明种子创业投资基金合伙企业（有限合伙）CN¥160M
A CNY160m specialist seed venture vehicle managed by Blue Ocean Capital’s Shenzhen fund-management company. It backs early neuroscience and brain-computer interface technologies, biotechnology, medical devices and health technology, including scientific teams commercializing research. Its investment and incubation model supports team formation, strategy, financing and product development.
Team
Operations and support
Duanqing PeiChief Scientist for Cell and Regenerative Medicine; Scientific and Industry Advisory Committee
Frank YangFounding Partner and Chief Executive Officer
Jean Paul ThierySenior Adviser; Scientific and Industry Advisory Committee
Jiang HuaSenior Industry Adviser; Scientific and Industry Advisory Committee
Li JixiSenior Adviser; Scientific and Industry Advisory Committee
